Tremfya Injection
Product Images NDC 57894-651

Product Visual Gallery

This gallery contains 31 technical images submitted to the FDA as part of the official labeling for Tremfya (NDC 57894-651). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Janssen Biotech, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (Tremfya 01)

A line graph depicting the percent of subjects over weeks in a clinical study comparing Tremfya (Guselkumab) 100 mg every 8 weeks versus placebo. The x-axis shows time in weeks (0 to 24) and the y-axis shows percent of subjects (0% to 100%). The graph includes two lines: a dashed line with open circles representing placebo subjects, and a solid line with filled triangles representing subjects taking Guselkumab 100 mg q8w. The Guselkumab line shows higher percent response over time compared to placebo.*

FDA Label Image

Tremfya 01a

TREMFYA (Guselkumab) injection syringe shown with a blue plunger and clear body, intended for intravenous use. The image depicts a pre-filled syringe consistent with available strengths of 100 mg/mL or 200 mg/20mL or 200 mg/2mL by Janssen Biotech, Inc.*

FDA Label Image

Figure (Tremfya 02)

TREMFYA 100 mg/mL injection vial label, a human prescription drug containing guselkumab. The label shows dosage form as injection for intravenous use. Manufacturer is Janssen Biotech, Inc. The vial is clear with a white cap and features dosage, usage, and lot information on the label.*

FDA Label Image

Figure (Tremfya 03)

An instructional diagram of a syringe used for TREMFYA (Guselkumab) injection, showing labeled parts including the plunger, safety guard, finger flange, syringe body, viewing window, and needle cover with warnings about handling the plunger and when to remove the needle cover before injection.*

FDA Label Image

Figure (Tremfya 04)

An instructional diagram illustrating the safety features of a prefilled injection syringe for TREMFYA (Guselkumab). It shows labeled parts including the plunger locks, safety guard activation, and needle retraction mechanism, demonstrating how the needle retracts into the syringe body for safe use and disposal.*

FDA Label Image

Figure (Tremfya 05)

An instructional illustration showing a rectangular product box labeled with a medication label. To the upper left is a clock graphic indicating 30 minutes, likely representing a required time duration related to the product.*

FDA Label Image

Figure (Tremfya 06)

An instructional illustration showing four blue adhesive patches applied to an arm, abdomen, and both thighs. The image likely depicts recommended sites for subcutaneous injection or placement of medication patches.*

FDA Label Image

Figure (Tremfya 07)

An instructional illustration showing two steps of hand hygiene: washing hands under running water with soap, and drying hands using a towel or cloth. The images emphasize proper hand cleaning technique.*

FDA Label Image

Figure (Tremfya 08)

An instructional illustration showing a close-up view of a syringe needle setup, highlighting the connection between the needle and the syringe barrel. The image appears to be part of usage instructions for an intravenous injection product.*

FDA Label Image

Figure (Tremfya 09)

An instructional illustration showing a hand holding a syringe with a needle pointing right and a small drop at the needle tip, with a cap or protective cover positioned to the left of the needle. The background is light gray, focusing on injection preparation technique.*

FDA Label Image

Figure (Tremfya 10)

An instructional illustration showing a hand holding a syringe at a 45-degree angle, preparing to inject into a forearm. The diagram emphasizes proper needle angle for intravenous injection.*

FDA Label Image

Figure (Tremfya 11)

An instructional illustration showing two hands preparing an injection syringe, demonstrating the process of drawing medication from a vial or preparing the syringe for intravenous administration.*

FDA Label Image

Figure (Tremfya 12)

An instructional illustration showing the assembly of a syringe and a vial adapter. The image is divided diagonally, with an arrow indicating the connection of the vial adapter to the syringe. It depicts hands holding and preparing the injection device, relevant to intravenous administration of TREMFYA (Guselkumab).*

FDA Label Image

Figure (Tremfya 13)

An instructional illustration showing a pair of hands holding a syringe. It depicts the process of pulling the syringe plunger back, indicated by a blue arrow pointing upward, likely to withdraw medication or air from the syringe barrel.*

FDA Label Image

Figure (Tremfya 14)

An instructional illustration showing a hand holding a prefilled syringe above a biohazard sharps disposal container. The image depicts proper disposal of an injection syringe into the red sharps container, emphasizing safe handling and disposal practices.*

FDA Label Image

Figure (Tremfya 15)

An instructional illustration showing a hand pressing a small cotton ball or gauze pad against skin, likely demonstrating a step in administering an injection or post-injection care for the drug Tremfya (Guselkumab) intravenous injection.*

FDA Label Image

Figure (Tremfya 16)

TREMFYA 100 mg/mL intravenous injection vial label by Janssen Biotech, Inc. The circular label includes the product name, concentration, dosage form, and visible regulatory markings with a blue and white color scheme.*

FDA Label Image

Principal Display Panel (100 mg/mL Syringe Carton)

An instructional illustration showing a white and teal medical injection device with a transparent base. It appears to be designed for intravenous administration, likely associated with TREMFYA (Guselkumab) injection delivery.*

FDA Label Image

Tremfya 18

An illustration diagram of an injection device for TREMFYA (guselkumab) showing labeled parts: handle, teal body, window, needle guard, and bottom cap. The diagram visually identifies components of the intravenous injection device used for administering the drug.*

FDA Label Image

Tremfya 19

An instructional illustration showing a box labeled "EXP" and a clock highlighting a 30-minute segment, indicating a time-related guidance likely for the TREMFYA (Guselkumab) injection product by Janssen Biotech, Inc.*

FDA Label Image

Tremfya 20

An instructional diagram depicting four blue adhesive patches applied to a person's body for intravenous injection sites. The patches are located on the upper arm, abdomen, lower back, and thigh, illustrating potential injection or treatment areas relevant to the intravenous injection route of TREMFYA (Guselkumab).*

FDA Label Image

Tremfya 21

An instructional illustration showing two separate hand actions: on the left, a hand being washed with water droplets falling; on the right, a hand pressing down on an injection site or similar area with a finger. The image likely demonstrates proper handwashing and site care related to drug administration.*

FDA Label Image

Tremfya 22

An instructional illustration showing a step in the preparation or administration process for an injection. The image depicts a syringe cap or needle cover being removed or positioned, with emphasis on the needle area, likely related to the intravenous injection of Tremfya (Guselkumab). No text or brand information is visible.*

FDA Label Image

Tremfya 23

An instructional illustration showing a hand holding a device with an arrow indicating a twisting motion to the left and a downward arrow. The image likely demonstrates how to unlock or activate a medication injection device for the drug TREMFYA (Guselkumab).*

FDA Label Image

Tremfya 24

An instructional illustration showing a hand holding a vial or syringe, tilted at a 90-degree angle, likely demonstrating a step in preparing or administering an injection.*

FDA Label Image

Tremfya 25

An instructional illustration showing a hand pressing down on a device or cap, with a blue downward arrow indicating the pressing action. The image likely demonstrates a step in the use or activation of an injection device for TREMFYA (Guselkumab) intravenous injection.*

FDA Label Image

Tremfya 26

An instructional illustration showing a hand pressing down on a device or cap with a "click" sound indicated, likely demonstrating the activation or opening mechanism of a product component.*

FDA Label Image

Tremfya 27

Illustration showing a hand pulling upward on a cap or cover from an injection vial or device, indicated by a blue arrow pointing upward, likely demonstrating how to remove the cap before use.*

FDA Label Image

Tremfya 28

An illustration showing a hand holding a used vial or syringe positioned above a red biohazard sharps disposal container with a biohazard symbol on the lid, indicating proper disposal of injection materials.*

FDA Label Image

Tremfya 29

An instructional illustration showing a hand pinching or lifting a fold of skin, likely demonstrating proper technique for an injection or subcutaneous administration site preparation.*

FDA Label Image

Tremfya 30

Packaging label for Tremfya (guselkumab) injection 100 mg/mL, a single-dose One-Press patient-controlled injector for subcutaneous use only. The label includes dosage instructions, discard warnings, and states no preservatives are in the product. Manufactured by Janssen Biotech, Inc., with labeling emphasizing patient-controlled injector and Rx only status.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.